Made by SterisWHO-GMP

Gliclaglaze Dapa 60-10

by Steris Healthcare Pvt. Ltd.

Be the first to review

Gliclazide 60 mg + Dapagliflozin 10 mg

GLICLAGLAZE DAPA 60-10 (Gliclazide SR 60 mg and Dapagliflozin 10 mg Tablets), manufactured by Steris Healthcare, is a dual-action oral anti-diabetic combination. It is indicated for the effective management of type 2 diabetes mellitus in adults when dual-mechanism therapy is required to achieve optimal glycemic control and offer cardiovascular and renal protection.

View medicine information ↓
Choose a pack
₹329.00₹470.0030% offinclusive of all taxes
Subscribe & save 5%Refill on your schedule · skip or cancel anytimeSave ₹16.45 every delivery
Set up autopay

Delivery estimate appears here

ManufacturerSteris Healthcare Pvt. Ltd.
Manufacturing qualityWHO-GMP verified
Expiry policyMinimum 3 months
ReviewedClinical review pending

Medicine information

Uses & overview

GLICLAGLAZE DAPA 60-10 by Steris Healthcare combines two complementary blood sugar-lowering agents: Gliclazide Sustained Release (60 mg) and Dapagliflozin (10 mg). By pairing a proven secretagogue with an SGLT2 inhibitor, this dual-action formula targets diabetes through two distinct pathways—stimulating natural insulin secretion and excreting excess blood glucose through urine. Key Uses & Clinical Benefits: Dual-Mechanism Glycemic Control: Effectively lowers both fasting and postprandial blood glucose levels, helping patients reach and maintain target HbA1c levels. Stimulates Natural Insulin Production: Gliclazide SR (a second-generation sulfonylurea) enhances insulin secretion from pancreatic beta-cells in response to meals. Excretes Excess Glucose: Dapagliflozin (an SGLT2 inhibitor) blocks glucose reabsorption in the kidneys, allowing excess sugar to be eliminated naturally through urine. Cardiovascular & Renal Benefits: Dapagliflozin provides extra protective benefits for heart health and helps reduce the risk of heart failure hospitalization and renal decline in diabetic patients. Sustained-Release Convenience: The 60 mg Sustained Release (SR) formulation of Gliclazide provides a steady therapeutic effect over 24 hours while minimizing the risk of sudden glycemic dips. How GLICLAGLAZE DAPA 60-10 Works: Gliclazide SR (60 mg): Selectively binds to sulfonylurea receptors on pancreatic beta-cells to stimulate controlled insulin release. Dapagliflozin (10 mg): Inhibits sodium-glucose co-transporter 2 (SGLT2) in the proximal renal tubules, decreasing renal glucose reabsorption without relying on insulin secretion.

How to use

Take 1 tablet of GLICLAGLAZE DAPA 60-10 once daily in the morning with breakfast or as directed by your physician. Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet, as doing so disrupts the sustained-release delivery system of Gliclazide. Stay well-hydrated throughout the day.

Storage

Store in a cool, dry place away from direct light, heat, and moisture. Store at a controlled room temperature below 30°C. Keep out of reach and sight of children.

Important guidance

Safety advice

Check with your doctor
AlcoholConsult your doctor

Avoid drinking alcohol while taking GLICLAGLAZE DAPA 60-10, as it increases the risk of severe hypoglycemia and dehydration.

PregnancyConsult your doctor

GLICLAGLAZE DAPA 60-10 is not recommended during pregnancy (especially during the second and third trimesters). Consult your doctor for safe alternatives like insulin.

BreastfeedingConsult your doctor

Do not use GLICLAGLAZE DAPA 60-10 while breastfeeding, as active ingredients may pass into breast milk and pose potential risks to the nursing infant.

DrivingConsult your doctor

Exercise caution while driving or operating machinery. Hypoglycemia (low blood sugar) caused by Gliclazide can cause dizziness and impair focus. Keep a quick source of sugar nearby.

KidneyConsult your doctor

Assessment of renal function is recommended prior to initiation. Dapagliflozin depends on kidney function for efficacy and requires medical monitoring in renal impairment.

LiverConsult your doctor

Use with caution in patients with severe hepatic impairment. Seek advice from your healthcare provider before starting therapy.

Clinical review pending

This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.

Customer feedback

Ratings & reviews

Be the first to review this product.

Loading reviews…

Write a review

Customers with a delivered order for this product can share their experience. Honest feedback of any rating is welcome.

0/3000 charactersChecking your sign-in status…

Same-salt substitutes

Frequently viewed together

OTC
Steris Folic Acid 26 product pack

Steris Folic Acid 26

Strip of 20 units

Folic Acid 100 mg

No reviews
₹89.10₹101.2512% off
OTC
Steris Folic Acid 86 product pack

Steris Folic Acid 86

Strip of 20 units

Folic Acid 100 mg

No reviews
₹155.10₹176.2512% off
Rx · H
Gliempaflozin Met Er 25 And 1000 product pack

Gliempaflozin Met Er 25 And 1000

For 10 Tablets

Empagliflozin 25 mg + Metformin Hydrochloride 1000 mg

No reviews
₹161.21₹230.3030% off
Prescription required before dispatch

Let’s help you order

Speak to our team about medicine availability, prescriptions or your order.

Opens your device’s calling app.